CRESCENT BIOPHARMA INC.

Historical 13F Holders

Symbol
CBIO
CUSIP
38000Q201
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 38000Q201 since 12/18/2024, newest first.

Filer % of Class Filed
Balyasny Asset Management L.P. 13G/A Amendment 1
6.0% 8/14/2026
Event 6/30/2026
Balyasny Asset Management L.P. 13G
5.5%
Checked 5% or less
5/15/2026
Event 3/31/2026
1Globe Capital LLC 13G/A Amendment 1
10.3% 10/14/2025
Event 10/7/2025
1Globe Capital LLC 13G
6.5% 8/20/2025
Event 8/13/2025
FMR LLC 13G
10.2% 7/8/2025
Event 6/30/2025
Venrock Healthcare Capital Partners III, L.P. 13G
9.9% 6/23/2025
Event 6/13/2025
Adage Capital Management, L.P. 13D/A Amendment 1
0.4% 6/20/2025
Event 6/20/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 2 473 k $8.51 M
2026 Q1 3 836 k $15.4 M
2025 Q4 2 374 k $161 k